Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

1. Labrador, J.
2. López-Corral, L.
3. López-Godino, O.
4. Vázquez, L.
5. Cabrero-Calvo, M.
6. Pérez-López, R.
7. Díez-Campelo, M.
8. Sánchez-Guijo, F.
9. Pérez-López, E.
10. Guerrero, C.
11. Alberca, I.
12. Del Cañizo, M.C.
13. Pérez-Simón, J.A.
14. González-Porras, J.R.
15. Caballero, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/BMT.2014.17 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus